Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
| GSK-3β inhibitor 2 | C14H14N4O3S | 1702428-31-6 | Details |
| GSK 525768A | C22H22ClN5O2 | 1260530-25-3 | Details |
| Molibresib besylate；GSK 525762C;I-BET 762 besylate | C28H28ClN5O5S | 1895049-20-3 | Details |
| GSK-5498A | C18H11F6N3O | 1253186-49-0 | Details |
| GSK-843；GSK'843 | C19H15N5S2 | 1601496-05-2 | Details |
| GSK3368715；EPZ019997 | C20H38N4O2 | 1629013-22-4 | Details |
| GSK3368715 dihydrochloride；EPZ019997 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
| GSK840；GSK'840 | C21H23N3O3 | 2361146-30-5 | Details |
| Epelsiban；GSK 557296 | C30H38N4O4 | 872599-83-2 | Details |
| GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
| GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
| GSK656 | C10H14BCl2NO4 | 2131798-13-3 | Details |
| GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
| GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| GSK3532795；BMS-955176 | C42H62N2O4S | 1392312-45-6 | Details |
| GSK2983559 free acid | C21H23N4O7PS2 | 1579965-12-0 | Details |
| GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
| GSK2945 | C20H18Cl2N2O2S | 1438071-12-5 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| Fenofibrate；Lipantil;Lipanthyl;Procetofen | C20H21ClO4 | 49562-28-9 | Details |
| GSK2850163 | C24H29Cl2N3O | 2121989-91-9 | Details |
| Fiboflapon sodium；GSK2190915 sodium salt;AM-803 sodium | C38H44N3NaO4S | 1196070-26-4 | Details |
| GSK2593074A；GSK'074 | C27H23N5OS | 1337531-06-2 | Details |
| GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
| Fiboflapon；AM-803;GSK2190915 | C38H43N3O4S | 936350-00-4 | Details |
| GSK-J2 | C22H23N5O2 | 1394854-52-4 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GSK256066 Trifluoroacetate；GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | C29H27F3N4O7S | 1415560-64-3 | Details |
| GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
| GSK2239633A | C24H25ClN4O5S2 | 1240516-71-5 | Details |
| Menbutone；Genabilin;Genabilic acid;Naftobil | C15H14O4 | 3562-99-0 | Details |
| GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
| GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
| GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| Guancydine；Guancidine | C7H14N4 | 1113-10-6 | Details |
| Camicinal；GSK962040 | C25H33FN4O | 923565-21-3 | Details |
| Camicinal hydrochloride；GSK962040 hydrochloride | C25H34ClFN4O | 923565-22-4 | Details |
| Guanfu base H；Atisinium chloride | C22H34ClNO2 | 4758-99-0 | Details |
| Roxithromycin；Roxl-150;RU-28965 | C41H76N2O15 | 80214-83-1 | Details |
| Guanfu base I；Acorine | C22H29NO5 | 110225-59-7 | Details |
| Guanosine-5'-triphosphate disodium salt；5'-GTP disodium salt | C10H17N5NaO14P3 | 56001-37-7 | Details |
| Guanoxabenz；Hydroxyguanabenz | C8H8Cl2N4O | 24047-25-4 | Details |
| Gum arabic；Arabic gum | N/A | 9000-01-5 | Details |
| Gusperimus trihydrochloride；BMS181173;NKT-01;Spanidin | C17H37N7O3.3ClH | 85468-01-5 | Details |
| Guaiapate；Mg 5454;Klamar | C18H29NO4 | 852-42-6 | Details |
| GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
| GSTO1-IN-1 | C10H12Cl2N2O3S | 568544-03-6 | Details |
| GV-58 | C18H26N6OS | 1402821-41-3 | Details |
| GZD856 | C29H27F3N6O | 1257628-64-0 | Details |
| GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
| GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
| GW 766994；GW 994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
| Albendazole；SKF-62979 | C12H15N3O2S | 54965-21-8 | Details |
| GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
| GW274150 | C8H17N3O2S | 210354-22-6 | Details |
| GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
| GV-196771A | C20H15Cl2N2NaO3 | 166974-23-8 | Details |
| Hck-IN-1 | C16H11ClN6O3S | 1473404-51-1 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| Haloperidol (D4')；Haloperidol D4' | C21H19ClD4FNO2 | 136765-35-0 | Details |
| Haloperidol D4 | C21H19ClD4FNO2 | 1189986-59-1 | Details |
| HA155；CS-963 | C24H19BFNO5S | 1312201-00-5 | Details |
| Haemanthamine | C17H19NO4 | 466-75-1 | Details |
| H4R antagonist 1 | C11H11BrN8 | 1429375-54-1 | Details |
| H3B-6545 | C30H29F4N5O2 | 2052130-80-8 | Details |
| H3B-6545 Hydrochloride | C30H30ClF4N5O2 | 2052132-51-9 | Details |
| Trimethoprim；NIH 204;BW 56-72;NSC-106568 | C14H18N4O3 | 738-70-5 | Details |
| H3B-120 | C19H24N4O2S | 2194903-42-7 | Details |
| GW311616 hydrochloride；GW311616A | C19H32ClN3O4S | 197890-44-1 | Details |
| DPP-IV-IN-2；H-Lys(4-nitro-Z)-pyrrolidide | C18H26N4O5 | 136259-18-2 | Details |
| H-Ser-His-OH | C9H14N4O4 | 67726-09-4 | Details |
| H100 | C18H16N2O6S | 643727-55-3 | Details |
| GW311616 | C19H31N3O4S | 198062-54-3 | Details |
| H-89；Protein kinase inhibitor H-89 | C20H20BrN3O2S | 127243-85-0 | Details |
| hDHODH-IN-1 | C17H14N2O2 | 1173715-42-8 | Details |
| HDACs/mTOR Inhibitor 1 | C28H38N8O5 | 2271413-06-8 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| HDAC-IN-5 | C26H24F3N5O2S | 1314890-51-1 | Details |
| HDAC-IN-4 | C20H21N3O2 | 1252003-13-6 | Details |
| HCV-IN-30 | C36H44N6O4 | 1007882-23-6 | Details |
| HCV-IN-3 | C13H11F2NO | 1401839-25-5 | Details |
| Rifaximin | C43H51N3O11 | 80621-81-4 | Details |
| HCV-IN-29 | C26H32Cl4N6 | 1009119-83-8 | Details |
| HCV-IN-7 hydrochloride | C40H49ClN8O6S | 1449756-87-9 | Details |
| Helioxanthin 8-1；Helioxanthin analogue 8-1 | C20H12N2O6 | 840529-13-7 | Details |
| Mebendazole；Vermox;Mebenvet;Telmin;Pantelmin | C16H13N3O3 | 31431-39-7 | Details |
| HCV-IN-7 | C40H48N8O6S | 1449756-86-8 | Details |
| hDHODH-IN-2 | C19H16N2O2 | 183946-00-1 | Details |
| Helioxanthin derivative 5-4-2；Helioxanthin 5-4-2 | C20H13NO5 | 203935-39-1 | Details |
| Helvolic acid；Fumigacin | C33H44O8 | 29400-42-8 | Details |
| hDDAH-1-IN-1 TFA | C10H21F3N4O3 | 1229238-70-3 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| Heptamidine dimethanesulfonate；SBi4211 dimethanesulfonate | C22H32N4O5S | 161374-55-6 | Details |
| Cathepsin Inhibitor 2 | C19H21F6N3O | 1017931-53-1 | Details |
| Heptamidine；SBi4211 | C21H28N4O2 | 94345-47-8 | Details |
| Heptasaccharide Glc4Xyl3 | C39H66O33 | 121591-98-8 | Details |
| HET0016 | C12H18N2O | 339068-25-6 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 | ||||